Skip to main content
Have a personal or library account? Click to login
Enediyne compounds - new promises in anticancer therapy Cover

Enediyne compounds - new promises in anticancer therapy

Open Access
|May 2007

References

  1. X. L. Yang and A. H.-J. Wang, Structural studies of atom-specific anticancer drugs acting on DNA,(1999) 181-215; DOI: 10.1016/S0163-7258(99)00020-0.
  2. N. A. Illan-Cabeza, R. A. Vilaplana, Y. Alvarez, K. Akdi, S. Kamah, F. Hueso-Urena, M. Quiros, F. Gonzalez-Vilchez and M. N. Moreno-Carretero, Synthesis, structure and biological activity of a new and efficient Cd(II)-uracil derivative complex system for cleavage of DNA,(2005) 924-934; DOI: 10.1007/s00775-005-0045-x.
  3. I. Haq and J. Ladbury, Drug-DNA recognition: Energetics and implications for design,(2000) 188-197; DOI: 10.1002/1099-1352(200007/08)13:4<188::AID-JMR503>3.0.CO;2-1.
  4. R. Barthwal, U. Sharma, N. Snivastava, M. Jain, P. Awasthi, M. Kaur, S. K. Barthwal and G. Govil, Structure of daunomycin complexed to d-TGATCA by two-dimensional nuclear magnetic resonance spectroscopy,(2006) 27-39; DOI: 10-1016/j.ejmech.2005.09.005.
  5. J. Chen and J. Stubbe, Bleomycins: new methods will allow reinvestigation of old issues,(2004) 175-181; DOI: 10.1016/j.cbpa.2004.02.008.
  6. S. E. Wolkenberg and D. L. Boger, Mechanisms of in situ activation for DNA-targeting antitumor agents,(2002) 2477-2495; DOI: 10.1021/cr010046q.
  7. Y. L. Janin, Peptides with anticancer use or potential,(2003) 1-40; DOI 10.1007/s00726-002-0349-xPeptides.
  8. I. Jerić, L. Šimičić, M. Stipetić and Š. Horvat, Synthesis and reactivity of the monosaccharide esters of amino acids as models of teichoic acid fragment,(2000) 273-282; DOI: 10.1023/A:1007157018792.
  9. I. Jerić and Š. Horvat, Novel ester-linked carbohydrate-peptide adducts: Effect of peptide substituent on the pathways of intramolecular reactions,(2001) 1533-1539; DOI: 10.1002/1099-0690(200104)2001:8<1533::AID-EJOC1533>3.0.CO;2-Y.
  10. I. Jerić, P. Novak, M. Vinković and Š. Horvat, Conformational analysis of sugar-peptide adducts in solution state by NMR spectroscopy and molecular modelling,, 1944-1950; DOI: 10.1039/b104239b.
  11. Š. Horvat, I. Jerić, L. Varga-Defterdarović, M. Roščić and J. Horvat, Ester-linked glycopeptides as tools for the study of biological phenomena,(2001) 787-799.
  12. I. Jerić, C. Versluis, Š. Horvat and A. J. R. Heck, Tracing glycoprotein structures: electrospray ionization tandem mass spectrometric analysis of sugar-peptide adducts,(2002) 803-811; DOI: 10.1002/jms.337.
  13. I. Jerić and Š. Horvat, Glycoconjugates as models in biomedical studies,(2004) 63-70.
  14. I. Jerić, Peptide mimetics: why and how?(2004) 495-504.
  15. I. Jerić and H. M. Chen,(Eds. M. Flegel, M. Fridkin, C. Gilon and J. Slaninova), Kenes International, Geneva 2005, pp. 218-219.
  16. I. Jerić, M. Momčilović, I. Bratoš and Š. Horvat, Synthesis of trehalose-centered dipeptide esters,(2006) 261-272.
  17. K. C. Nicolaou, A. L. Smith, and E. W. Yue, Chemistry and biology of natural and designed enediynes,(1993) 5881-5888.
  18. A. L. Smith and K. C. Nicolaou, The enediyne antibiotics,(1996) 2103-2117; DOI: 10.1021/jm9600398.
  19. K. Edo, M. Mizugaki, Y. Koide, H. Seto, K. Furihata, N. Otake and N. Ishida, The structure of neocarzinostatin chromophore possessing a novel bicyclo-[7,3,0]dodecadiyne system,(1985) 331-334; DOI: 10.1016/S0040-4039(1)80810-8.
  20. M. D. Lee, T. S. Dunne, C. C. Chang, G. A. Ellestad, M. M. Siegel, G. O. Morton, W. J. McGahren and D. B Borders, Calichemicins, a novel family of antitumor antibiotics. 2. Chemistry and structure of calichemicin gamma1I,(1987) 3466-3468; DOI: 10.1021/ja00245a051.
  21. J. Golik, J. Clardy, G. Dubay, G. Groenwold, H. Kawaguchi, M. Konishi, B. Krishnan, H. Ohkuma, K. Saitoh and T. W. Doyle, Esperamicins, a novel class of potent antitumor antibiotics. 2. Structure of esperamicin X,(1987) 3461-3462; DOI: 10.1021/ja00245a048.
  22. M. Konishi, H. Ohkuma, T. Tsuno, T. Oki, G. D. VanDuyne and J. Clardy, Crystal and molecular structure of dynemicin A: A novel 1,5-diyn-3-ene antitumor antibiotic,(1990) 3715-3716; DOI: 10.1021/ja00165a097.
  23. R. R. Jones and R. G. Bergman,-Benzyne: Generation as an intermediate in a thermal isomerization reaction and trapping evidence for the 1,4-benzenediyl structure.(1972) 660-661; DOI: 10.1021/ja00757a071.
  24. P. C. Dedon, A. A. Salzberg and J. Xu, Exclusive production of bistranded DNA damage by calicheamicin,(1993) 3617-3622; DOI: 10.1021/bi00065a013.
  25. J. W. Grissom, G. U. Gunawardena, D. Klingberg and D. Huang, The chemistry of enediynes, enyne, allens and related compounds,(1996) 6453-6518; DOI: 10.1016/0040-4020 (96)00016-6.
  26. E. W. Schmitt, J. C. Huffman and J. M. Zaleski, Thermal reactivities of isostructural dmetal-loenediynes: metal-dependent Bergman cyclization,2001, 167-168; DOI: 10.1039/b008337m.
  27. I. Saito and K. Nakatani, Design of DNA-cleaving agents,(1996) 3007-3019; DOI: 10.1246/bcsj.69.3007.
  28. H. H. Wenk, M. Winkler and W. Sander, One century of aryne chemistry,(2003) 502-528; DOI: 10.1002/anie.200390151.
  29. K. C. Nicolaou, G. Zuccarello, C. Riemer, V. A. Estevez and W.-M. Dai, Design, synthesis and study of simple monocyclic conjugated - enediynes. The 10-membered ring enediyne moiety of the enediyne anticancer antibiotics,(1992) 7360-7371; DOI: 10.1021/ja00045a005.
  30. M. E. Maier and T. Brandstetter, Synthesis of an oxabicyclo[7.2.1.] enediyne from a furanoside derivative,(1992) 7511-7514; DOI: 10.1016/s0040-4039(00)60-810-9.
  31. S. Bhattacharyya, M. Pink, M.-H. Baik and J. M. Zaleski, A unique approach to metal-induced Bergman cyclization: long range enediyne activation by ligand-to-metal charge transfer,(2005) 592-595; DOI: 10.1002/anie.200461825.
  32. D. L. Boger and J. Zhou, CDPI3-enediyne and CDPI3-EDTA conjugates: a new class of DNA cleaving agents,(1993) 3018-3024; DOI: 10.1021/jo0006a019.
  33. N. Ishida, K. Miyazaki, K. Kumagai and M. Rikimaru, Neocarzinostatin, an antitumor antibiotic of high molecular weight,(1965) 68-76.
  34. M. F. Semmelhack, J. J. Gallagher, W.-D. Ding, G. Krishnamurthy, R. Babine and G. A. Ellestad, The effect on DNA cleavage potency of tethering a simple cyclic enediyne to a netropsin analog,(1994) 4357-4359; DOI: 10.1021/jo00095a002.
  35. N. Zein, A. M. Casazza, T. W. Doyle, J. E. Leet, D. R. Schroeder, W. Solomon and S. G. Nadler, Selective proteolitic activity of the antitumor agent kedarcidin,(1993) 8009-8012; DOI: 10.1073/pnas.90.17.8009.
  36. C. G. Sudhahar and D. H. Chin, Aponeocarzinostatin - A superior drug carrier exhibiting unusually high endurance against denaturants,(2006) 3543-3552; DOI: 10.1016/j.bmc.2006.01.012.
  37. N. F. Schor, V. E. Kagan, Ye Liang, Ch. Yan, Yu. Tyurina, V. Tyurin and K. D. Nylander, Exploiting oxidative stress and signaling in chemotherapy of resistant neoplasms,(Moscow)(2004) 38-44; DOI: 10.1023/B:BIRY.0000016349.75384.e6.
  38. N. Zein, M. Poncin, R. Nilakantan and G. A. Ellestad, Calicheamicin γand DNA: Molecular recognition process responsible for site-specificity;(1989) 697-699.
  39. S. Walker, J. Murnick and D. Kahne, Structural characterization of a calicheamicin-DNA complex by NMR,(1993) 7954-7961; DOI: 10.1021/ja00071a004.
  40. N. K. Damle, Tumour-targeted chemotherapy with immunoconjugates of calicheamicin,(2004) 1445-1452; DOI: 10.1517/14712598.4.9.1445.
  41. K. C. Nicolaou and W.-M. Dai, Chemistry and biology of the enediyne anticancer antibiotics,(1991) 1387-1416; DOI: 10.1002/anie.199113873.
  42. S. Feldgus, Expanding the cancer fighting arsenal,
  43. S. C. Sinha, Lian-Sheng Li, G. P. Miller, S. Dutta, C. Rader and R. A. Lerner, Prodrugs of dynemicin analogs for selective chemotherapy mediated by an aldose catalytic Ab,(2004) 3095-3099; DOI: 10.1073/pnas.0307319101.
  44. Y. Suguira, T. Shiraki, M. Konishi and T. Oki, DNA Intercalation and cleavage of an antitumor antibiotic dynemicin that contains anthracycline and enediyne cores,(1990) 3831-3835; DOI: 10.1073/pnas.87.10.3831.
DOI: https://doi.org/10.2478/v10007-007-0011-y | Journal eISSN: 1846-9558 | Journal ISSN: 1330-0075
Language: English, Croatian
Page range: 133 - 150
Published on: May 16, 2007
Published by: Croatian Pharmaceutical Society
In partnership with: Paradigm Publishing Services
Related subjects:

© 2007 Matija Gredičak, Ivanka Jerić, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons License.